Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Completed Phase 1 Interventional Accepts healthy volunteers Results available

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female Subjects

ClinicalTrials.gov ID: NCT00928083

Public ClinicalTrials.gov record NCT00928083. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Study To Investigate The Safety, Tolerability And Pharmacokinetic Profile Of OZ439 In Healthy Male and Female Subjects

Study identification

NCT ID
NCT00928083
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Medicines for Malaria Venture
Other
Enrollment
63 participants

Conditions and interventions

Interventions

  • OZ439 50mg API capsules Drug
  • OZ439 200mg API capsules Drug
  • OZ439 400mg aqueous dispersion Drug
  • OZ439 800mg aqueous dispersion Drug
  • OZ439 100mg API capsules Drug
  • OZ439 400mg API capsules Drug
  • OZ439 1600mg aqueous dispersion Drug
  • OZ439 800mg API capsules Drug
  • OZ439 1200mg API capsules Drug
  • Placebo Drug
  • OZ439 200mg aqueous dispersion Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2009
Primary completion
Sep 30, 2009
Completion
Nov 30, 2009
Last update posted
Jan 7, 2015

2009

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Comprehensive Phase One Miramar; 3400 Enterprise Way Miramar Florida 33025 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00928083, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2015 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00928083 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →